Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3663)

[861]

Novotna, M.; Havlicek, J.; Smith, A.P.; Kolbekova, P.; Skallova, A.; Klose, J.; Gasova, Z.; Pisacka, M.; Sechovska, M.; Flegr, J.

Toxoplasma and reaction time : role of toxoplasmosis in the origin, preservation and geographical distribution of Rh blood group polymorphism

[year of publication 2008, impact factor 2.071]

[862]

Písačka, M.

International forum : quality assurance, quality control and accreditation

[year of publication 2006, impact factor 2.067]

[863]

de Swart, L.; Smith, A.; Haase, D.; Fenaux, P.; Symeonidis, A.; Cermak, J.; et al.

Prognostic impact of a suboptimal number of analyzed metaphases in normal karyotype lower-risk MDS

[year of publication 2018, impact factor 2.066 ]

[864]

Miyazaki, Y.; Tuechler, H.; Sanz, G.; Schanz, J.; Garcia-Manero, G.; Solé, F.; Bennett, J.M.; Bowen, D.; Fenaux, P.; Dreyfus, F.; Kantarjian, H.; Kuendgen, A.; Malcovati, L.; Cazzola, M.; Cermak, J.; et al.

Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: analysis from the International Working Group for Prognosis of MDS

[year of publication 2018, impact factor 2.066 ]

[865]

Jonasova, A.; Neuwirtova, R.; Polackova, H.; Siskova, M.; Stopka, T.; Cmunt, E.; Belickova, M.; Moudra, A.; Minarik, L.; Fuchs, O.; Michalova, K.; Zemanova, Z.

Lenalidomide treatment in lower risk myelodysplastic syndromes: the experience of a Czech hematology center. (Positive effect of erythropoietin ± prednisone addition to lenalidomide in refractory or relapsed patients)

[year of publication 2018, impact factor 2.066 ]

[866]

Sarova, I.; Brezinova, J.; Zemanova, Z.; Ransdorfova, S.; Svobodova, K.; Izakova, S.; Pavlistova, L.; Lizcova, L.; Berkova, A.; Skipalova, K.; Hodanova, L.; Salek, C.; Jonasova, A.; Michalova, K.

High frequency of dicentric chromosomes detected by multi-centromeric FISH in patients with acute myeloid leukemia and complex karyotype

[year of publication 2018, impact factor 2.066 ]

[867]

Brodská, B.; Otevřelová, P.; Holoubek, A.

Decitabine-induced apoptosis is derived by Puma and Noxa induction in chronic myeloid leukemia cell line as well as in PBL and is potentiated by SAHA

[year of publication 2010, impact factor 2.057 ]

[868]

Souček, J.; Poučková, P.; Strohalm, J.; Plocová, D.; Hloušková, D.; Zadinová, M.; Ulbrich, K.

Poly [N-(2-hydroxypropyl)methacrylamide] conjugates of bovine pancreatic ribonuclease (RNase A) inhibit growth of human melanoma in nude mice

[year of publication 2006, impact factor 2.045]

[869]

Vrana, M.; Siffnerova, V.; Pecherkova, P.; Ratajova, E.; Sonka, K.

Distribution of HLA-DQB1 in Czech patients with central hypersomnias

[year of publication 2017, impact factor 2.040 ]

[870]

Kotlín, R.; Chytilová, M.; Suttnar, J.; Riedel, T.; Salaj, P.; Blatný, J.; Šantrůček, J.; Klener, P.; Dyr, J. E.

Fibrinogen Nový Jičín and Praha II : cases of hereditary A alpha 16 Arg to Cys and A alpha 16 Arg to His dysfibrinogenemia

[year of publication 2008, impact factor 2.038]

[871]

Lukas, J.; Bartek, J.; Strauss, M.

Efficient transfer of antibodies into mammalian cells by electroporation

[year of publication 2006, impact factor 2.029]

[872]

Hamsikova, E.; Smahelova, J.; Ludvikova, V.; Salakova, M.; Rychla, J.; Skrenkova, J.; Rob, L.; Tachezy, R.

The prevalence of HPV infections in HPV-vaccinated women from the general population

[year of publication 2017, impact factor 2.026 ]

[873]

Lemež, P.

Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m(2)/day

[year of publication 2006, impact factor 2.017]

[874]

aut. Suttnar, Jiří

Solid phase extraction in malondialdehyde analysis

[year of publication 2006, impact factor 2.017]

[875]

Kubeš, R.; Salaj, P.; Hromádka, R.; Včelák, J.; et al.

Range of motion after total knee arthroplasty in hemophilic arthropathy

[year of publication 2018, impact factor 2.002 ]

[876]

Palek, J.; Jarolim, P.

Clinical and expression and laboratory detection of red blood cell membrane protein mutations

[year of publication 2006, impact factor 1.994]

[877]

Zivny, J.; Jelinek, J.; Pospisilova, D.; Plasilova, M.; Necas, E.; Stopka, T.

Diamond Blackfan anemia stem cells fail to repopulate erythropoiesis in NOD/SCID mice

[year of publication 2006, impact factor 1.991]

[878]

Vyoral, D.; Petrák, J.

Detection and quantification of 59Fe labeled proteins using storage phosphorimaging

[year of publication 2006, impact factor 1.991]

[879]

Veselá, R.; Doležalová, L.; Pytlík, R.; Rychtrmocová, H.; Marečková, H.; Trněný, M.

The evaluation of survival and proliferation of lymphocytes in autologous mixed leukocyte reaction with dendritic cells. The comparison of incorporation of 3H-thymidine and differential gating method

[year of publication 2011, impact factor 1.974 ]

[880]

Valka, J.; Vesela, J.; Votavova, H.; Dostalova-Merkerova, M.; Urbanova, Z.; Jonasova, A.; Cermak, J.; Belickova, M.

Genetic variant screening of DNA repair genes in myelodysplastic syndrome identifies a novel mutation in the XRCC2 gene

[year of publication 2019, impact factor 1.967 ]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 305

Deputy head of Science and Research Division
Tel:+420 221 977 648

Secretary
Tel:+420 221 977 144


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here